Hantavirus is harmless to over 100 mammal species but kills a third of the humans it infects. The reason comes down to a few strands of RNA we never inherited.
The cruise ship MV Hondius docked in Tenerife last week with eight people aboard who had tested positive for hantavirus. Three of them were dead. The ship had spent five weeks crossing the South Atlantic, stopping at remote islands and Antarctic coastline, and somewhere in that chain the virus had crossed into a human body and not stopped.
It crossed, then it killed.
What it had never done, in any of the more than one hundred other mammal species it lives in, is make those animals sick.
The gap
Stanford Medicine has noted that hantavirus has been detected in more than a hundred species of mammals, including foxes and bats, but lives primarily in wild rodents. In a deer mouse, hantavirus is a long, quiet tenancy. The animal carries the virus for the rest of its life and shows no symptoms at all.
In us, the fatality rate is around thirty-five percent in US cases over recent decades, and reaches up to fifty percent across the Americas more broadly.
Plenty of viruses are dangerous. The strange thing about hantavirus is the asymmetry. The same molecular intruder, sitting quietly in one body and tearing another apart.
For most of medical history, we have talked about disease as a property of the pathogen. The virus does X. The bacterium does Y. The framing puts the cause in the visitor, not the host. It is a useful shorthand. It is also incomplete.
What actually kills people
A 2024 paper in Nature Communications traced what happens, cell by cell, when Hantaan virus, a related Asian hantavirus species, enters rodent tissue versus human tissue. The virus replicates in both. The early inflammatory response looks similar in both. Then the trajectories split.
In mice, a series of small RNA molecules begins to brake the inflammatory response. Macrophages that initially raised the alarm get rewired, switched from a pro-inflammatory state into a pro-resolution one. The fire is put out before it can spread.
Humans don't have these molecules. Our immune system keeps going. Macrophages keep recruiting more macrophages, cytokines keep climbing, the lungs fill with fluid because our own capillaries have become too permeable to hold it back. Most people who die of hantavirus die of this inflammatory cascade, not from direct viral damage to their cells.
The Stanford article puts it more cautiously. "It clearly affects the lungs," Jorge Salinas, an infectious disease specialist at Stanford Health Care, said in the interview. "But it's not clear how much of that is the virus attacking the lung cells versus the response of our body to the infection."
The Nature paper is less ambiguous. The response of our body is, by some measures, the entire disease.
What "carrier" obscures
The language we use to describe reservoir species hides this. We call a deer mouse a carrier. We say the virus lives in wild rodents. The framing makes the animal sound like a passive vehicle, a delivery system for something that belongs somewhere else.
The virus has been in deer mice for as long as deer mice have been deer mice. The relationship is old. From inside the mouse's body, there is no carriage and no infection. Just a tenant whose presence triggers no alarm.
When the virus meets us, it does not change. We do.
This is the pattern across most of zoonosis. Reservoir host research has shown that Egyptian fruit bats can host Marburg virus for months without symptoms while shedding it efficiently into shared spaces. Various bat species do something similar with rabies, with henipaviruses, with the coronaviruses that occasionally cross into humans. About three-quarters of emerging infectious diseases are zoonotic. The cause sits on our side of the relationship. We keep meeting their viruses for the first time.
What we are looking at, when we look at a reservoir species, is a body that has worked out how to live with something we cannot.
The body that doesn't escalate
Disease ecologists distinguish between two kinds of defense. Resistance is the immune system fighting off a pathogen and clearing it. Tolerance is the immune system allowing infection to happen and surviving the having of it. The reservoir species, for the viruses that matter most to them, have evolved tolerance.
This sounds like a soft skill. It is a measurable trait. Researchers can watch it in tissue samples: which macrophages quiet down, which cytokines stop climbing, which capillary beds hold their integrity. The mouse's immune system has been tuned, over evolutionary timescales of carrying this particular virus, to know when to stop.
Things the rodent body does in hantavirus infection that ours does not:
- Quiets inflammatory macrophages on a timetable, before they recruit reinforcements
- Restrains the cytokine cascade once the virus has been registered
- Maintains capillary integrity in lung tissue even with viral RNA in circulation
- Persists as a competent host of the virus without progressing to disease
We are not built for any of that, against this particular virus. Our immune system meets hantavirus the way it would meet a much more dangerous pathogen, and we drown in our own response.
What this changes about the news
A great deal of what we read about emerging diseases is framed as a story of dangerous animals encroaching on us. Wild rodents, sick bats, ticking-bomb species. The Stanford piece is careful to push back on this for hantavirus specifically: house mice in suburban garages are not the usual carriers, the cruise outbreak is unlikely to repeat, the global risk is low.
There is a deeper push-back available, and the Stanford piece does not make it. The danger lives in the meeting between us and them. We are the part of the system that has not worked out how to coexist with what we keep encountering. Mice, bats, foxes have figured it out for the viruses that matter to them. The new position in this old arrangement is ours.
This does not make the cruise outbreak less frightening. Three people died. The Andes strain of hantavirus is the only one documented to transmit between humans, and it is dangerous in ways that the more common North American strains are not. The WHO is right to track it carefully.
It does change what we are looking at when we look at the next outbreak.
The molecules we don't have
What surprised me most, reading the macrophage study, was how specific the difference is. A small set of regulatory molecules, present in mice and absent in us. A pause button that one body has and another doesn't. The gap between life and death, for the people on that cruise ship and for the eleven people who died in the 2018 Argentinian outbreak, can be traced down to a few strands of noncoding RNA that we never inherited.
We will keep crossing paths with these viruses. The climate is shifting, populations are moving, the boundaries between where we live and where reservoir species live are getting thinner. There is no version of the near future in which we encounter fewer of them.
What there might be is a version in which we stop calling them carriers and start calling them what they more nearly are. Bodies that have done the work, over millions of years, of figuring out how to live with what is in them. The work is not done in us yet. It might never be.
For now, we are the species that meets a virus once and cannot stop telling its own immune system to wait.
